Asset Allocation

As of December 31, 2025.
Type % Net
Cash 52.33%
Stock 27.47%
Bond 16.77%
Convertible 0.00%
Preferred 0.00%
Other 3.43%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 50.58%    % Emerging Markets: 0.22%    % Unidentified Markets: 49.20%

Americas 50.06%
49.26%
Canada 0.09%
United States 49.17%
0.80%
Colombia 0.01%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.53%
United Kingdom 0.21%
0.29%
Belgium 0.00%
France 0.02%
Ireland 0.10%
Italy 0.01%
Sweden 0.00%
Switzerland 0.11%
0.00%
0.03%
Israel 0.03%
Greater Asia 0.21%
Japan 0.00%
0.00%
Australia 0.00%
0.05%
Singapore 0.05%
0.16%
Thailand 0.16%
Unidentified Region 49.20%

Bond Credit Quality Exposure

AAA 0.00%
AA 0.21%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.01%
Not Available 99.79%
Short Term 0.00%
As of December 31, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
36.09%
Materials
4.36%
Consumer Discretionary
8.93%
Financials
17.50%
Real Estate
5.29%
Sensitive
39.22%
Communication Services
2.73%
Energy
4.75%
Industrials
17.11%
Information Technology
14.61%
Defensive
23.14%
Consumer Staples
1.84%
Health Care
18.33%
Utilities
2.98%
Not Classified
1.55%
Non Classified Equity
0.68%
Not Classified - Non Equity
0.87%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 99.99%
Corporate 0.01%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
99.94%
Less than 1 Year
99.94%
Intermediate
0.06%
1 to 3 Years
0.06%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of December 31, 2025
View Bond Maturity Exposure
Start Trial